Trial Profile
An open label clinical pilot study with local injection of human antibody (HuMax-Inflam) for the treatment of inflammatory psoriasis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2012
Price :
$35
*
At a glance
- Drugs HuMax IL8 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Genmab
- 28 Aug 2011 New trial record